HOME >> BIOLOGY >> NEWS
Charting the future in prostate cancer care: A call to action

LOS ANGELES, Sept. 9 -- This year, an estimated 230,000 men will be diagnosed with prostate cancer in the United States, and 30,000 are expected to die from the disease. Today, about two million men are battling prostate cancer, and over the next decade, about three million more will be compelled to join the war. The need for new therapies is great, and since 1993, The Prostate Cancer Foundation has played a pivotal role in supporting and funding R&D breakthroughs to defeat this disease.

The timing is becoming ever more critical. As the baby boomer men reach the target age for prostate cancer, beginning at age 50, this disease will become the cancer with the greatest increase in incidence, in addition to being the most common non-skin cancer in the U.S. In fact, over the next decade, the number of new prostate cancer cases in the U.S. is expected to increase by 50 percent to more than 300,000 new cases per year. Unfortunately, even today, prostate cancer treatment and research has lagged behind other areas, such as that of breast cancer, where there has been recent progress in integration among specialties and late-stage innovation of new therapeutics.

On September 22, 2004, the Prostate Cancer Foundation (PCF) will release its Report to the Nation on Prostate Cancer, authored by 24 leading prostate cancer experts. A distinguished panel will present the major findings of the Report and its authors' calls to action to address the urgent need to improve the management of prostate cancer and accelerate the development of better treatments and a cure. The PCF will also debut a public service announcement campaign "It's a TEAM Approach: Prostate Cancer Treatment, Education, Awareness and Management". The PSA features golf legend Arnold Palmer, a prostate cancer survivor, who encourages a multi-disciplinary team approach to this deadly disease, which affects one in six men in their lifetime.

Who: Panelists and Special Gues
'"/>

Contact: Justin Jackson
jjackson@burnsmc.com
212-213-0006
Burns McClellan
9-Sep-2004


Page: 1 2 3

Related biology news :

1. Lights, Camera ... Reaction: Charting The Biological Effects Of Light InBillionths Of A Second
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. Sandia experiments may reduce possibility of future water wars
4. Will a reduction in military spending improve our environmental future?
5. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
6. Engineering endurance: The future of the Olympics?
7. The future of nanotechnology
8. Chemoradioimmunotherapy for advanced breast cancer: hope for the future?
9. Endometriosis: Could angiostatic therapy be the new treatment of the future?
10. Plants for the future: A European vision for plant biotechnology towards 2025
11. Plant pathologists to discuss the future of organic farming

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... antibody development services, today announced that the company has received ISO9001:2015 certification ... pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates ...
(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online ... with Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology ... announced on June 16 that starting July 5 it would begin offering ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... ... Amniosomes special offer. This includes buy three, get the fourth unit free with ... , Amniotic derived exosomes, known as exosomes, have been a game changer for ...
(Date:6/23/2020)... ... 2020 , ... Nobilis Therapeutics, a biopharmaceutical company focused on ... Investigational New Drug application (IND) with the U.S. Food & Drug Administration (FDA) ... in patients with panic disorder (PD). , "Adding a PD trial to a ...
(Date:6/11/2020)... ... , ... Greffex, a leading genetic engineering company, with the ... vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce ... successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments including ...
(Date:6/11/2020)... ... June 09, 2020 , ... ... the NEON Micro-Tracer Solution, a highly accurate, contact tracing solution for ... the workplace. Contact tracing, a core disease control measure, is a key strategy ...
Breaking Biology Technology:
Cached News: